A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers

NCT05563961 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis
Pharmacology

Interventions

DRUG: Panadol®
DRUG: SafeTynadol®

Sponsor

Sinew Pharma Inc.